First-Line Treatments for Poor-Prognosis Metastatic Renal Cell

First-Line Treatments for Poor-Prognosis Metastatic Renal Cell

First-Line Treatments for Poor-Prognosis Metastatic Renal Cell Carcinoma: Experts’
Prescribing Practices and Systematic Literature Review
Clinical Drug Investigation
Olivia Le Saux1,2, Gilles Freyer2, Sylvie Négrier1
1
Centre Léon Bérard, Université de Lyon, 28, rue Laennec, F-69373 Lyon Cedex 08, France.
2
Centre Hospitalier Lyon Sud, Institut de Cancérologie des Hospices Civils de Lyon,
Université de Lyon, Pierre-Bénite, France.
Corresponding author: Olivia Le Saux
[email protected]
The experts who completed the questionnaire are: 1) Sergio Bracarda 2) Tim Eisen 3) Bernard Escudier 4) Viktor Gruenwald 5) James Larkin 6) Sylvie Négrier 7) Camillo Porta 8) Manuela Schmidinger 9) Cora N. Sternberg 10) Nizar Tannir